Association between cardiovascular risk factors and stage 1 hypertension defined by the 2017 ACC/AHA guidelines

References

• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37–55. doi:10.1016/S0140-6736(16)31919-5. Cited in PubMed; PMID: 27863813.
   PubMed Web of Science ®Google Scholar
• Aladin AI, Al Rifai M, Rasool SH, Dardari Z, Yeboah J, Nasir K, Budoff MJ, Psaty BM, Blumenthal RS, Blaha MJ, et al. Relation of coronary artery calcium and extra-coronary aortic calcium to incident hypertension (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2018;121(2):210–16. doi:10.1016/j.amjcard.2017.10.018. Cited in PubMed; PMID: 29174140.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006. Cited in PubMed; PMID: 29146535.
   PubMed Web of Science ®Google Scholar
• Qi Y, Han X, Zhao D, Wang W, Wang M, Sun J, Liu J, Li Y, Gao S, Hao Y, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;72(11):1201–10. doi:10.1016/j.jacc.2018.06.056. Cited in PubMed; PMID: 30189996.
   PubMed Web of Science ®Google Scholar
• Hardy ST, Loehr LR, Butler KR, Chakladar S, Chang PP, Folsom AR, Heiss G, MacLehose RF, Matsushita K, Avery CL. Reducing the blood pressure-related burden of cardiovascular disease: impact of achievable improvements in blood pressure prevention and control. J Am Heart Assoc. 2015;4(10):e002276. doi:10.1161/JAHA.115.002276. Cited in PubMed; PMID: 26508742.
   PubMed Web of Science ®Google Scholar
• Fan J, Xu JH, Wang J, Wang GZ, Zhang YQ, Liu XZ. Effects of laparoscopic adjustable gastric banding on weight loss, metabolism, and obesity-related comorbidities: 5-year results in China. Obes Surg. 2014;24(6):891–96. doi:10.1007/s11695-013-1173-y. Cited in PubMed; PMID: 24402722.
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. doi:10.1016/S0140-6736(03)15268-3. Cited in PubMed; PMID: 14726171.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Gao Y, Fan J, Xu X, Zhang J, Gao J, Wan W, Zhao DB. Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. Clin Rheumatol. 2018;37(1):219–26. doi:10.1007/s10067-017-3847-7. Cited in PubMed; PMID: 28944421.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Li HH, Huang S, Zhao DB. 2019. Association between hyperuricemia and nontraditional adiposity indices. Clin Rheumatol. 38(4):1055–62. doi:10.1007/s10067-018-4374-x
   PubMed Web of Science ®Google Scholar
• Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C, et al. Predicting the 10-Year risks of atherosclerotic cardiovascular disease in chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation. 2016;134(19):1430–40. doi:10.1161/CIRCULATIONAHA.116.022367. Cited in PubMed; PMID: 27682885.
   PubMed Web of Science ®Google Scholar
• Li HH, Huang S, Liu XZ, Zou DJ. 2019. Applying the China-PAR risk algorithm to assess 10-year atherosclerotic cardiovascular disease risk in populations receiving routine physical examinations in Eastern China. Biomed Environ Sci. 32(2):87–95. doi:10.3967/bes2019.014
   PubMed Web of Science ®Google Scholar
• Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899–911. doi:10.1016/S0140-6736(14)60685-1. Cited in PubMed; PMID: 24881994.
   PubMed Web of Science ®Google Scholar
• Shen L, Ma H, Xiang MX, Wang JA. Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. Am J Cardiol. 2013;112(2):266–71. doi:10.1016/j.amjcard.2013.03.023. Cited in PubMed; PMID: 23608614.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, Xu D. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013;11:177. doi:10.1186/1741-7015-11-177.
   PubMed Web of Science ®Google Scholar
• Tian J, Sheng CS, Sun W, Song X, Wang H, Li Q, W L, Wang W. 2018. Effects of high blood pressure on cardiovascular disease events among chinese adults with different glucose metabolism. Diabetes Care. 41(9):1895–900. doi:10.2337/dc18-0918
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA. Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world. JAMA. 2018;319(2):115–16. doi:10.1001/jama.2017.19672. Cited in PubMed; PMID: 29242891.
   PubMed Web of Science ®Google Scholar
• Zhang WH, Zhang L, An WF, Ma JL. Prehypertension and clustering of cardiovascular risk factors among adults in suburban Beijing, China. J Epidemiol. 2011;21(6):440–46. doi:10.2188/jea.JE20110022. Cited in PubMed; PMID: 21946627.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the strong heart study. Hypertension. 2006;47(3):410–14. doi:10.1161/01.HYP.0000205119.19804.08. Cited in PubMed; PMID: 16446387.
   PubMed Web of Science ®Google Scholar
• Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, Hoefler M, Unger T, Sharma AM. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens. 2004;17(10):904–10. doi:10.1016/j.amjhyper.2004.05.017. Cited in PubMed; PMID: 15485752.
   PubMed Web of Science ®Google Scholar
• Drøyvold WB, Midthjell K, Nilsen TI, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond). 2005;29(6):650–55. doi:10.1038/sj.ijo.0802944. Cited in PubMed; PMID: 15809666.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med. 1967;67(1):48–59. doi:10.7326/0003-4819-67-1-48. Cited in PubMed; PMID: 6028658.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Yin K, Fan J, Shen XJ, Xu MJ, Wang WH, Zhang YG, Zheng CZ, Zou da J. Long-term outcomes and experience of laparoscopic adjustable gastric banding: one center’s results in China. Surg Obes Relat Dis. 2015;11(4):855–59. doi:10.1016/j.soard.2014.09.021. Cited in PubMed; PMID: 25862180.
   PubMed Web of Science ®Google Scholar
• Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124(24):e837–41. doi:10.1161/CIRCULATIONAHA.111.077602. Cited in PubMed; PMID: 22156000.
   PubMed Web of Science ®Google Scholar
• Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, Sharma P, Fraser C, MacLennan G. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. 2017;359:j4849. doi:10.1136/bmj.j4849.
   PubMed Web of Science ®Google Scholar
• Khosravi A, Emamian MH, Hashemi H, Fotouhi A. Pre-hypertension and the risk of diabetes mellitus incidence using a marginal structural model in an Iranian prospective cohort study. Epidemiol Health. 2018;40:e2018026–0. doi:10.4178/epih.e2018026. Cited in PubMed; PMID: 30056646.
   PubMed Web of Science ®Google Scholar
• Fan J, Gao ST, Wang LJ, Qian ZL, Zhou ZQ, Liu XZ. Association of three simple insulin resistance indexes with prehypertension in normoglycemic subjects. Metab Syndr Relat Disord. 2019;17(7):374–79. doi:10.1089/met.2019.0029. Cited in PubMed; PMID: 31211636.
   Google Scholar
• Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 2018;71(3):422–28. doi:10.1161/HYPERTENSIONAHA.117.10546. Cited in PubMed; PMID: 29335249.
   PubMed Web of Science ®Google Scholar
• Khosravi A, Gharipour M, Nezafati P, Khosravi Z, Sadeghi M, Khaledifar A, Taheri M, Golshahi J, Sarrafzadegan N. 2017. Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term? J Hum Hypertens. 31(6):382–87. doi:10.1038/jhh.2016.42
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Tabara Y, Kohara K, Kusunoki T, Abe M, Miki T. Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clin Exp Hypertens. 2014;36(1):64–69. doi:10.3109/10641963.2013.789043. Cited in PubMed; PMID: 24164146.
   PubMed Web of Science ®Google Scholar
• Karasek D, Vaverkova H, Halenka M, Jackuliakova D, Frysak Z, Orsag J, Novotny D. Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(1):41–49. doi:10.5507/bp.2012.046. Cited in PubMed; PMID: 23073522.
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T, et al. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-Year Japanese cohort study. Hypertension. 2018;71(1):78–86. doi:10.1161/HYPERTENSIONAHA.117.10370. Cited in PubMed; PMID: 29203632.
   PubMed Web of Science ®Google Scholar
• Wang B, Lin L, Zhao C. Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia. Clin Exp Hypertens. 2016;38(3):312–16. doi:10.3109/10641963.2015.1107088. Cited in PubMed; PMID: 27028508.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Li HH, Huang S, Zhao DB. 2018 Nov 29. Association between hyperuricemia and nontraditional adiposity indices. Clin Rheumatol. doi:10.1007/s10067-018-4374-x. Cited in PubMed; [Epub ahead of print] PMID: 30498873.
   Web of Science ®Google Scholar
• Han T, Lan L, Qu R, Xu Q, Jiang R, Na L, Sun C. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension. 2017;70(4):703–11. doi:10.1161/HYPERTENSIONAHA.117.09508. Cited in PubMed; PMID: 28808071.
   PubMed Web of Science ®Google Scholar
• Cheng YB, Li Y. Hyperuricemia: does it matter for the progression from prehypertension to hypertension? Hypertension. 2018;71(1):66–67. doi:10.1161/HYPERTENSIONAHA.117.10443. Cited in PubMed; PMID: 29203631.
   PubMed Web of Science ®Google Scholar